These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Non-invasive prenatal diagnosis: progress and potential. Daley R; Hill M; Chitty LS Arch Dis Child Fetal Neonatal Ed; 2014 Sep; 99(5):F426-30. PubMed ID: 24786470 [TBL] [Abstract][Full Text] [Related]
25. Cell-free fetal nucleic acid testing: a review of the technology and its applications. Sayres LC; Cho MK Obstet Gynecol Surv; 2011 Jul; 66(7):431-42. PubMed ID: 21944155 [TBL] [Abstract][Full Text] [Related]
26. Noninvasive prenatal detection of aneuploidy. Robinson C; van den Boom D; Bombard AT Clin Obstet Gynecol; 2014 Mar; 57(1):210-25. PubMed ID: 24351443 [TBL] [Abstract][Full Text] [Related]
27. Cell-Free DNA Screening: Complexities and Challenges of Clinical Implementation. Grace MR; Hardisty E; Dotters-Katz SK; Vora NL; Kuller JA Obstet Gynecol Surv; 2016 Aug; 71(8):477-87. PubMed ID: 27526871 [TBL] [Abstract][Full Text] [Related]
28. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening. Wagner AJ; Mitchell ME; Tomita-Mitchell A Clin Perinatol; 2014 Dec; 41(4):957-66. PubMed ID: 25459783 [TBL] [Abstract][Full Text] [Related]
29. Prenatal screening for chromosome abnormalities. Chitty L Br Med Bull; 1998; 54(4):839-56. PubMed ID: 10367418 [TBL] [Abstract][Full Text] [Related]
30. Noninvasive prenatal diagnosis in 2020. Lo YM Prenat Diagn; 2010 Jul; 30(7):702-3. PubMed ID: 20572103 [No Abstract] [Full Text] [Related]
31. A new era in noninvasive prenatal testing. Morain S; Greene MF; Mello MM N Engl J Med; 2013 Aug; 369(6):499-501. PubMed ID: 23862975 [No Abstract] [Full Text] [Related]
32. How to choose a test for prenatal genetic diagnosis: a practical overview. Sparks TN; Dugoff L Am J Obstet Gynecol; 2023 Feb; 228(2):178-186. PubMed ID: 36029833 [TBL] [Abstract][Full Text] [Related]
33. Cell-free fetal DNA testing for fetal aneuploidy and beyond: clinical integration challenges in the US context. Allyse M; Sayres LC; King JS; Norton ME; Cho MK Hum Reprod; 2012 Nov; 27(11):3123-31. PubMed ID: 22863603 [TBL] [Abstract][Full Text] [Related]
34. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Gregg AR; Gross SJ; Best RG; Monaghan KG; Bajaj K; Skotko BG; Thompson BH; Watson MS Genet Med; 2013 May; 15(5):395-8. PubMed ID: 23558255 [TBL] [Abstract][Full Text] [Related]
35. [New frontiers in noninvasive, prenatal screening and diagnosis: fetal DNA circulating in maternal blood]. Montagnana M; Lippi G; Guidi GC Minerva Ginecol; 2007 Jun; 59(3):331-41. PubMed ID: 17576408 [TBL] [Abstract][Full Text] [Related]
36. [What are the real purpose and scope of screening for aneuploidy?]. Quibel T; Rozenberg P Gynecol Obstet Fertil Senol; 2018 Feb; 46(2):124-129. PubMed ID: 29396076 [TBL] [Abstract][Full Text] [Related]
37. Immediate and long-term applications of technology. Holzgreve W; Nippert I; Gänshirt-Ahlert D; Schloo R; Miny P Clin Obstet Gynecol; 1993 Sep; 36(3):476-84. PubMed ID: 8403599 [TBL] [Abstract][Full Text] [Related]
38. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing. Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661 [TBL] [Abstract][Full Text] [Related]
40. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory. Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]